A cancer vaccine is reducing the chances that melanoma patients’ tumors return

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck. (AP Video/Lekan Oyekanmi; Production/Shelby Lum)

Subscribe: http://smarturl.it/AssociatedPress
Read more: https://apnews.com​

This video may be available for archive licensing via https://newsroom.ap.org/home